Protein engineering strategies for the development of viral vaccines and immunotherapeutics

Jayne F. Koellhoffer, Chelsea D. Higgins, Jonathan R. Lai

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Vaccines that elicit a protective broadly neutralizing antibody (bNAb) response and monoclonal antibody therapies are critical for the treatment and prevention of viral infections. However, isolation of protective neutralizing antibodies has been challenging for some viruses, notably those with high antigenic diversity or those that do not elicit a bNAb response in the course of natural infection. Here, we discuss recent work that employs protein engineering strategies to design immunogens that elicit bNAbs or engineer novel bNAbs. We highlight the use of rational, computational, and combinatorial strategies and assess the potential of these approaches for the development of new vaccines and immunotherapeutics.

Original languageEnglish (US)
Pages (from-to)298-307
Number of pages10
JournalFEBS Letters
Volume588
Issue number2
DOIs
StatePublished - Jan 21 2014

Fingerprint

Viral Vaccines
Protein Engineering
Neutralizing Antibodies
Antibody Formation
Vaccines
Antigenic Variation
Proteins
Virus Diseases
Viruses
Monoclonal Antibodies
Engineers
Infection
Therapeutics

Keywords

  • Antibody engineering
  • Antiviral immunotherapy
  • Immunogen design

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Structural Biology

Cite this

Protein engineering strategies for the development of viral vaccines and immunotherapeutics. / Koellhoffer, Jayne F.; Higgins, Chelsea D.; Lai, Jonathan R.

In: FEBS Letters, Vol. 588, No. 2, 21.01.2014, p. 298-307.

Research output: Contribution to journalArticle

Koellhoffer, Jayne F. ; Higgins, Chelsea D. ; Lai, Jonathan R. / Protein engineering strategies for the development of viral vaccines and immunotherapeutics. In: FEBS Letters. 2014 ; Vol. 588, No. 2. pp. 298-307.
@article{7a5954c18ea147cd9ad3cc0932ad2840,
title = "Protein engineering strategies for the development of viral vaccines and immunotherapeutics",
abstract = "Vaccines that elicit a protective broadly neutralizing antibody (bNAb) response and monoclonal antibody therapies are critical for the treatment and prevention of viral infections. However, isolation of protective neutralizing antibodies has been challenging for some viruses, notably those with high antigenic diversity or those that do not elicit a bNAb response in the course of natural infection. Here, we discuss recent work that employs protein engineering strategies to design immunogens that elicit bNAbs or engineer novel bNAbs. We highlight the use of rational, computational, and combinatorial strategies and assess the potential of these approaches for the development of new vaccines and immunotherapeutics.",
keywords = "Antibody engineering, Antiviral immunotherapy, Immunogen design",
author = "Koellhoffer, {Jayne F.} and Higgins, {Chelsea D.} and Lai, {Jonathan R.}",
year = "2014",
month = "1",
day = "21",
doi = "10.1016/j.febslet.2013.10.014",
language = "English (US)",
volume = "588",
pages = "298--307",
journal = "FEBS Letters",
issn = "0014-5793",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Protein engineering strategies for the development of viral vaccines and immunotherapeutics

AU - Koellhoffer, Jayne F.

AU - Higgins, Chelsea D.

AU - Lai, Jonathan R.

PY - 2014/1/21

Y1 - 2014/1/21

N2 - Vaccines that elicit a protective broadly neutralizing antibody (bNAb) response and monoclonal antibody therapies are critical for the treatment and prevention of viral infections. However, isolation of protective neutralizing antibodies has been challenging for some viruses, notably those with high antigenic diversity or those that do not elicit a bNAb response in the course of natural infection. Here, we discuss recent work that employs protein engineering strategies to design immunogens that elicit bNAbs or engineer novel bNAbs. We highlight the use of rational, computational, and combinatorial strategies and assess the potential of these approaches for the development of new vaccines and immunotherapeutics.

AB - Vaccines that elicit a protective broadly neutralizing antibody (bNAb) response and monoclonal antibody therapies are critical for the treatment and prevention of viral infections. However, isolation of protective neutralizing antibodies has been challenging for some viruses, notably those with high antigenic diversity or those that do not elicit a bNAb response in the course of natural infection. Here, we discuss recent work that employs protein engineering strategies to design immunogens that elicit bNAbs or engineer novel bNAbs. We highlight the use of rational, computational, and combinatorial strategies and assess the potential of these approaches for the development of new vaccines and immunotherapeutics.

KW - Antibody engineering

KW - Antiviral immunotherapy

KW - Immunogen design

UR - http://www.scopus.com/inward/record.url?scp=84892373125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892373125&partnerID=8YFLogxK

U2 - 10.1016/j.febslet.2013.10.014

DO - 10.1016/j.febslet.2013.10.014

M3 - Article

C2 - 24157357

AN - SCOPUS:84892373125

VL - 588

SP - 298

EP - 307

JO - FEBS Letters

JF - FEBS Letters

SN - 0014-5793

IS - 2

ER -